FIELD: medicine.
SUBSTANCE: present invention relates to the treatment of cholestatic itching. A method for the treatment of cholestatic itching related to primary biliary cholangitis includes oral administration of a compound, which is seladelpar or its pharmaceutically acceptable salt.
EFFECT: development of a method for the treatment of cholestatic itching.
6 cl, 3 ex
Title |
Year |
Author |
Number |
TREATMENT OF INTRAHEPATIC CHOLESTATIC DISEASES |
2017 |
- Baudes Pol
- Makuerter Charlz A.
|
RU2765460C2 |
METHODS OF USING AGONISTS FXR |
2017 |
- Laffitte, Bryan
- Badman, Michael
- Chen, Jin
- Lindgren, Sam
|
RU2737324C2 |
METHODS FOR INCREASING HEIGHT OF PEDIATRIC PATIENTS WITH CHOLESTATIC LIVER DISEASE |
2020 |
- Jaecklin, Thomas
- Dorenbaum, Alejandro
|
RU2822484C2 |
USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS |
2014 |
- Zhang Xiaoming
- Schnipper Edward F.
- Perlman Andrew J.
- Larrick James W.
|
RU2666219C2 |
FXR AGONISTS APPLICATION METHODS |
2017 |
- Laffitte, Bryan
- Badman, Michael
- Chen, Jin
- Lindgren, Sam
|
RU2743075C2 |
ANTAGONISTS OF TOL-LIKE RECEPTOR 4 AND USE IN AUTOIMMUNE LIVER DISEASES |
2016 |
- U, Edvin, Essi
- Tszyu, Piter Dzhejes
- Syuj, Mej-Tszi
- Shi, In-Chzhu
|
RU2707560C2 |
PHARMACEUTICAL COMPOSITIONS SUITABLE FOR DELIVERY TO JOINT AND THEIR USE IN TREATMENT OF JOINT PAIN |
2019 |
- Tsen, Yun-Lun
- Shikh, Sheue-Fan
- Chan, Po-Chun
- Chan, Lu
|
RU2810788C2 |
COMPOSITIONS AND METHODS FOR MYELOFIBROSIS TREATMENT |
2011 |
- Dzhajan Arvind
- Kakejs Dzhenis
- Tefferi Ejalu
|
RU2616262C2 |
METHOD OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) WITH USING CYSTEAMINE PRODUCTS |
2008 |
- Dokhil Randzhan
- Shnajder Dzherri
|
RU2498795C2 |
KAPPA-OPIOID AGONISTS FOR TREATMENT OF DIARRHEA-PREVAILING IRRITABLE BOWEL SYNDROME AND ALTERNATE IRRITABLE BOWEL SYNDROME |
2008 |
|
RU2441655C2 |